Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132677) titled 'Safety and efficacy of KD025 in reducing intraocular pressure: a double-blind, randomized, controlled clinical trial' on Sept. 17.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Sanmenxia Central Hospital
Condition:
Glaucoma
Intervention:
Experimental group:Give KD025 eye drops
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-17
Target Sample Size: Experimental group:10;Control group:10;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=340913
Published by HT Digital Content Services with pe...